Virulence and antibiotic resistance of pseudomonas aeruginosa isolated from patients with urinary tract infections in southern Poland

Chemotherapy

Volumn 60, Issue 4, 2014, Pages 253-260

  Pobiega, Monika ^a   Wojkowska Mach, Jadwiga ^a   Maciag, Joanna ^a   Chmielarczyk, Agnieszka ^a   Romaniszyn, Dorota ^a   Pomorska Wesolowska, Monika ^b   Ziolkowski, Grzegorz ^c   Heczko, Piotr B ^a   Bulanda, Malgorzata ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b SILESIAN UNIVERSITY OF TECHNOLOGY   (Poland)

^c Higher School of Medicine in Sosnowiec   (Poland)

Author keywords

Antimicrobial susceptibilities; Multidrug resistance; Polymicrobial infections; Pseudomonas aeruginosa; Urinary tract infections

Indexed keywords

AMIKACIN; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC PLUS TICARCILLIN; COLISTIN; DORIPENEM; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; METALLO BETA LACTAMASE; NETILMICIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; BETA LACTAMASE OXA 10 GENE; BETA LACTAMASE SHV GENE; BETA LACTAMASE TEM GENE; BETA LACTAMASE VIM 2 GENE; CHILD; CONTROLLED STUDY; FEMALE; GENE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE; NONHUMAN; OUTPATIENT; POLAND; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SCHOOL CHILD; URINARY TRACT INFECTION; YOUNG ADULT; CLINICAL TRIAL; DRUG EFFECTS; EPIDEMIOLOGY; ISOLATION AND PURIFICATION; MULTICENTER STUDY; PATHOGENICITY; PHYSIOLOGY; PSEUDOMONAS INFECTIONS; URINARY TRACT INFECTIONS; URINE; VIRULENCE;

ADULT; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; MIDDLE AGED; POLAND; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; URINARY TRACT INFECTIONS; VIRULENCE;

EID: 84929965855     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000376569     Document Type: Article

References (43)

1. Shigemura K, Arakawa S, Sakai Y, Kinoshita S, Tanaka K, Fujisawa M: Complicated urinary tract infection caused by Pseudomonas aeruginosa in a single institution (1999-2003). Int J Urol 2006; 13: 538-542.
2. Tielen P, Narten M, Rosin N, Biegler I, Haddad I, Hogardt M, Neubauer R, Schobert M, Wiehlmann L, Jahn D: Genotypic and phenotypic characterization of Pseudomonas aeruginosa isolates from urinary tract infections. Int J Med Microbiol 2011; 301: 282-292.
3. Ferreira AM, Bonesso MF, Mondelli AL, Camargo CH, Cunha Mde L: Oxacillin resistance and antimicrobial susceptibility profile of Staphylococcus saprophyticus and other staphylococci isolated from patients with urinary tract infection. Chemotherapy 2012; 58: 482-491.
4. Jarvis WR, Martone WJ: Predominant pathogens in hospital infections. J Antimicrob Chemother 1992; 29(suppl A):19-24.
5. Moore KN, Day RA, Albers M: Pathogenesis of urinary tract infections: a review. J Clin Nurs 2002; 11: 568-574.
6. Ronald A: The etiology of urinary tract infection: traditional and emerging pathogens. Dis Mon 2003; 49: 71-82.
7. Obritsch MD, Fish DN, MacLaren R, Jung R: National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002. Antimicrob Agents Chemother 2004; 48: 4606-4610.
8. Rosenthal VD, Bijie H, Maki DG, Mehta Y, Apisarnthanarak A, Medeiros EA, Leblebicioglu H, Fisher D, Alvarez-Moreno C, Khader IA, Del Rocio Gonzalez Martinez M, Cuellar LE, Navoa-Ng JA, Abouqal R, Guanche Garcell H, Mitrev Z, Pirez Garcia MC, Hamdi A, Duenas L, Cancel E, Gurskis V, Rasslan O, Ahmed A, Kanj SS, Ugalde OC, Mapp T, Raka L, Yuet Meng C, Thu le TA, Ghazal S, Gikas A, Narvaez LP, Mejia N, Hadjieva N, Gamar Elanbya MO, Guzman Siritt ME, Jayatilleke K: INICC members: International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009. Am J Infect Control 2012; 40: 396-407.
9. Narten M, Rosin N, Schobert N, Tielen P: Susceptibility of Pseudomonas aeruginosa urinary tract isolates and influence of urinary tract conditions on antibiotic tolerance. Curr Microbiol 2012; 64: 7-16.
10. Rossolini GM: Acquired metallo-beta-lactamases: an increasing clinical threat. Clin Infect Dis 2005; 41: 1557-1558.
11. Grabe M, Bjerklund-Johansen T, Botto H, Wullt B, Cek M, Naber K, Pickard R, Tenke P, Wagenlehner P: Guidelines on urological infections. European Association of Urology. http://www.uroweb.org/gls/pdf/15-Urological-Infections.pdf, 2014.
12. Williams GJ, Hodson EH, Isaacs D, Craig JC: Diagnosis and management of urinary tract infection in children. J Paediatr Child Health 2012; 48: 296-301.
13. Hamood AN, Griswold JA, Duhan CM: Production of extracellular virulence factors by Pseudomonas aeruginosa isolates obtained from tracheal, urinary tract, and wound infections. J Surg Res 1996; 61: 425-432.
14. Bogiel T, Mikucka A, Skalski T, Gospodarek E: Occurrence and susceptibility to antibiotics of carbapenem-resistant Pseudomonas aeruginosa strains between 1998 and 2009 (in Polish). Med Dosw Mikrobiol 2010; 62: 221-229.
15. Lukowicz M, Weber-Rajek M, Ciechanowska-Mendyk K: Urinary tract infection in patient after brain injury (in Polish). Przegl Lek 2011; 68: 146-149.
16. Bartoszko-Tyczkowska A, Gaszynski W, Baranowska A, Tyczkowska-Sieron E: Nosocomial infection control in intensive therapy (in Polish). Anestezjol Intens Ter 2008; 40: 232-236.
17. Gales AC, Jones RN, Turnidge J, Rennie R, Ramphal R: Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001; 32(suppl 2):S146-S155.
18. Ajayi T, Allmond LR, Sawa T, Wiener-Kronish JP: Single-nucleotide-polymorphism mapping of the Pseudomonas aeruginosa type III secretion toxins for development of a diagnostic multiplex PCR system. J Clin Microbiol 2003; 41: 3526-3531.
19. Andrejko M, Zdybicka-Barabas A, Janczarek M, Cytrynska M: Three Pseudomonas aeruginosa strains with different protease profiles. Acta Biochim Pol 2013; 60: 83-90.
20. Finnan S, Morrissey JP, O'Gara F, Boyd EF: Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment. J Clin Microbiol 2004; 42: 5783-5792.
21. Lee K, Lim YS, Yong D, Yum JH, Chong Y: Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2003; 41: 4623-4629.
22. Doi Y, Potoski BA, Adams-Haduch JM, Sidjabat HE, Pasculle AW, Paterson DL: Simple disk-based method for detection of Klebsiella pneumoniae carbapenemase-type beta-lactamase by use of a boronic acid compound. J Clin Microbiol 2008; 46: 4083-4086.
23. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL: Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18: 268-281.
24. Franco MR, Caiaffa-Filho HH, Burattini MN, Rossi F: Metallo-beta-lactamases among imipenem-resistant Pseudomonas aeruginosa in a Brazilian university hospital. Clinics (Sao Paulo) 2010; 65: 825-829.
25. Yakupogullari Y, Poirel L, Bernabeu S, Kizirgil A, Nordmann P: Multidrug-resistant Pseudomonas aeruginosa isolate co-expressing extended-spectrum beta-lactamase PER-1 and metallo-beta-lactamase VIM-2 from Turkey. J Antimicrob Chemother 2008; 61: 221-222.
26. Wang C, Cai P, Chang D, Mi Z: A Pseudomonas aeruginosa isolate producing the GES-5 extended-spectrum beta-lactamase. J Antimicrob Chemother 2006; 57: 1261-1262.
27. Rayamajhi N, Kang SG, Lee DY, Kang ML, Lee SI, Park KY, Lee HS, Yoo HS: Characterization of TEM-, SHV-and AmpC-type betalactamases from cephalosporin-resistant Enterobacteriaceae isolated from swine. Int J Food Microbiol 2008; 124: 183-187.
28. Naas T, Philippon L, Poirel L, Ronco E, Nordmann P: An SHV-derived extended-spectrum beta-lactamase in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1999; 43: 1281-1284.
29. Bhattacharjee A, Sen MR, Prakash P, Anupurba S: Role of beta-lactamase inhibitors in enterobacterial isolates producing extendedspectrum beta-lactamases. J Antimicrob Chemother 2008; 61: 309-314.
30. Schechner V, Straus-Robinson K, Schwartz D, Pfeffer I, Tarabeia J, Moskovich R, Chmelnitsky I, Schwaber MJ, Carmeli Y, Navon-Venezia S: Evaluation of PCR-based testing for surveillance of KPC-producing carbapenem-resistant members of the Enterobacteriaceae family. J Clin Microbiol 2009; 47: 3261-3265.
31. Chlabicz S, Leszczynska K, Lukas W, Gualco L, Schito G, Naber KG: Uncomplicated lower urinary tract infections in females-clinical aspects, aetiology and antimicrobial resistance epidemiology. Results of the ARESC (Antimicrobial Resistance Epidemiological Survey on Cystitis) study in Poland and their implications for empiric therapy (in Polish). Przegl Epidemiol 2011; 65: 345-351.
32. Hryniewicz K, Szczypa K, Sulikowska A, Jankowski K, Betlejewska K, Hryniewicz W: Antibiotic susceptibility of bacterial strains isolated from urinary tract infections in Poland. J Antimicrob Chemother 2001; 47: 773-780.
33. Yoon BI, Kim HS, Kim SD, Cho KJ, Kim SW, Ha US, Cho YH, Sohn DW: Changes in bacterial species and antibiotic sensitivity in intensive care unit: acquired urinary tract infection during 10 years interval (2001-2011). Urol J 2014; 11: 1478-1484.
34. Laupland KB, Bagshaw SM, Gregson DB, Kirkpatrick AW, Ross T, Church DL: Intensive care unit-acquired urinary tract infections in a regional critical care system. Crit Care 2005; 9:R60-R65.
35. Tissot E, Limat S, Cornette C, Capellier G: Risk factors for catheter-associated bacteriuria in a medical intensive care unit. Eur J Clin Microbiol Infect Dis 2001; 20: 260-262.
36. Rumbaugh KP, Griswold JA, Hamood AN: Pseudomonas aeruginosa strains obtained from patients with tracheal, urinary tract and wound infection: variations in virulence factors and virulence genes. J Hosp Infect 1999; 43: 211-218.
37. Mitov I, Strateva T, Markova B: Prevalence of virulence genes among Bulgarian nosocomial and cystic fibrosis isolates of Pseudomonas aeruginosa. Braz J Microbiol 2010; 41: 588-595.
38. Toder DS, Ferrell SJ, Nezezon JL, Rust L, Iglewski BH: lasA and lasB genes of Pseudomonas aeruginosa: analysis of transcription and gene product activity. Infect Immun 1994; 62: 1320-1327.
39. Gendrel D, Chalumeau M, Moulin F, Raymond J: Fluoroquinolones in paediatrics: a risk for the patient or for the community? Lancet Infect Dis 2003; 3: 537-546.
40. Walsh TR, Toleman MA, Poirel L, Nordmann P: Metallo-beta-lactamases: the quiet before the storm? Clin Microbiol Rev 2005; 18: 306-325.
41. Samuelsen O, Toleman MA, Sundsfjord A, Rydberg J, Leegaard TM, Walder M, Lia A, Ranheim TE, Rajendra Y, Hermansen NO, Walsh TR, Giske CG: Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion. Antimicrob Agents Chemother 2010; 54: 346-352.
42. Pournaras S, Maniati M, Petinaki E, Tzouvelekis LS, Tsakris A, Legakis NJ, Maniatis AN: Hospital outbreak of multiple clones of Pseudomonas aeruginosa carrying the unrelated metallo-beta-lactamase gene variants blaVIM-2 and blaVIM-4. J Antimicrob Chemother 2003; 51: 1409-1414.
43. Inacio HS, Bomfim MR, Franca RO, Farias LM, Carvalho MA, Serufo JC, Santos SG: Phenotypic and genotypic diversity of multidrugresistant Pseudomonas aeruginosa isolates from bloodstream infections recovered in the Hospitals of Belo Horizonte, Brazil. Chemotherapy 2014; 60: 54-62.